Insider Trading History of Graboyes Marc H

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Graboyes Marc H since 2006. The trader's CIK number is 1305811. At the time of the last reporting, Graboyes Marc H was the VP, General Counsel of Allos Therapeutics Inc. (stock ticker symbol ALTH). Also see all insider trading activities at Allos Therapeutics Inc.


Yearly summary of insider trading at Allos Therapeutics Inc (ALTH) by Graboyes Marc H

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 ALTH 0 $0 24,390 $36,999 0 $0
2011 ALTH 0 $0 19,704 $37,621 0 $0
2010 ALTH 913 $4,756 78,765 $671,610 75,000 $202,500
2009 ALTH 0 $0 125,000 $926,037 125,000 $269,350
2006 ALTH 2,500 $4,547 0 $0 0 $0
2006 ALTH 1,888 $3,434 0 $0 0 $0


Insider trading of Allos Therapeutics Inc (ALTH) by Graboyes Marc H

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-02-29 ALTH Sale 9,425 1.52 14,363
2012-03-01 ALTH Sale 9,635 1.48 14,259
2012-02-23 ALTH Sale 3,950 1.58 6,252
2012-02-24 ALTH Sale 1,380 1.54 2,125
2011-11-15 ALTH Sale 14,494 1.44 20,900
2011-02-24 ALTH Sale 1,410 3.12 4,406
2011-02-23 ALTH Sale 3,800 3.24 12,315
2010-06-30 ALTH Buy 913 5.21 4,756
2010-04-12 ALTH Option Ex 75,000 2.70 202,500
2010-04-12 ALTH Sale 75,000 8.58 643,500
2010-02-23 ALTH Sale 1,416 7.51 10,634
2010-02-24 ALTH Sale 2,349 7.44 17,476
2009-08-03 ALTH Option Ex 50,000 2.39 119,350
2009-08-03 ALTH Sale 50,000 8.00 400,000
2009-03-13 ALTH Option Ex 5,864 2.00 11,728
2009-03-12 ALTH Option Ex 69,136 2.00 138,272
2009-03-13 ALTH Sale 5,864 7.00 41,048
2009-03-12 ALTH Sale 69,136 7.01 484,989
2006-12-29 ALTH Buy 2,500 1.82 4,547
2006-06-30 ALTH Buy 1,888 1.82 3,434

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Graboyes Marc H (VP, General Counsel of Allos Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.